MTF

Teledyne e2v announces next generation high-performance CMOS image sensors for extreme low light conditions

Retrieved on: 
Tuesday, January 16, 2024
CMOS, Science, Documentation, CFA, SNR, HDR, Quantum, Astronomy, Teledyne Technologies, MTF, Television

GRENOBLE, France, Jan. 16, 2024 (GLOBE NEWSWIRE) --  Teledyne e2v, a Teledyne Technologies company and global innovator of imaging solutions, announces OnyxMax™, the next generation of its popular Onyx 1.3M low light CMOS image sensor.

Key Points: 
  • GRENOBLE, France, Jan. 16, 2024 (GLOBE NEWSWIRE) --  Teledyne e2v, a Teledyne Technologies company and global innovator of imaging solutions, announces OnyxMax™, the next generation of its popular Onyx 1.3M low light CMOS image sensor.
  • This new sensor has been designed for extremely low light conditions, down to 1 mLux.
  • The combination of sensitivity and image resolution increases its range, allowing even small objects to be detected in harsh conditions.
  • Ariane Le Bon, Marketing Manager for Low Noise Imaging, at Teledyne e2v said, “We are very proud to release OnyxMax, which has been specifically designed to deliver high-performance in challenging low light conditions.

AAC Showcases Seven Integrated Solutions at CES 2024, Accelerating AI for a Digital World

Retrieved on: 
Friday, January 12, 2024
Synthetic media, RF, Noise, Acoustics, Research, TWS, GPS, Software design, Kool-Aid, Transsion, Vibration, Multimedia, XR, VFW, AOP, OnePlus, AAC, Electronics, AI, TTL, SNR, Algorithm, Pancake, MIX, MEMS, Exhibition, USS, PSS, WLG, Microphone, NVH, Original equipment manufacturer, Ultra, Tablet, Smartglasses, LHP, Turbocharger, Engineering, FOV, Lens, Mechanics, MTF, Cassette tape

In the era of AI, AAC showcased its integrated solutions across seven domains – intelligent automotive, acoustics, haptic feedback, XR, optics, precision manufacturing, and sensors & semiconductors.

Key Points: 
  • In the era of AI, AAC showcased its integrated solutions across seven domains – intelligent automotive, acoustics, haptic feedback, XR, optics, precision manufacturing, and sensors & semiconductors.
  • In the acoustics and haptics world, AAC presented Opera, a coaxial speaker designed for smartphones, along with the related algorithms.
  • The key and cornerstone of constructing a digital world with AI lie in upgrading perceptual experiences at the audio-visual-tactile entry level.
  • AAC, through its seven integrated solutions, is collaboratively working towards enhancing perceptual experiences for global consumers.

Canadian Government Awards New Funding to General Fusion

Retrieved on: 
Tuesday, December 5, 2023
Federal, Government, Research, Plasma, The Honourable, Columbia, Strategic Innovation Fund, Laser, Economic development, General Fusion, Magnetized target fusion, Coal, MTF, Face, Investment, Federation, Lithium

By 2100, the production and export of the Canadian industry’s fusion energy technology could provide up to $1.26 trillion in economic benefits to Canada.

Key Points: 
  • By 2100, the production and export of the Canadian industry’s fusion energy technology could provide up to $1.26 trillion in economic benefits to Canada.
  • When commercialized, a single General Fusion power plant will be designed to provide zero-carbon power to approximately 150,000 Canadian homes, with the ability to be placed close to energy demand at a cost competitive with other energy sources such as coal and natural gas.1
    “For more than 20 years, General Fusion has advanced its uniquely practical Magnetized Target Fusion technology and IP at its Canadian headquarters.
  • Government announced CA$5 million in provincial support for General Fusion’s homegrown technology, and we’re pleased to see the Federal government has now provided funds to support General Fusion.
  • The Canadian government is investing an additional CA$5 million for a total of CA$54.3 million to support the development of General Fusion’s energy technology through the Strategic Innovation Fund program.

FlexTrade and LSEG Collaborate to Deliver a Fully Integrated FX Solution

Retrieved on: 
Thursday, December 21, 2023
Software, Banking, Networks, Internet, Professional Services, Business, Data Management, Electronic Commerce, Technology, Digital Cash Management, Digital Assets, Asset Management, Finance, Partnership, FX, EMS, MTF, FXall, Senior, Financial services

The partnership between LSEG and FlexTrade will enable new mutual clients access to FXall execution services from within the FlexFX EMS.

Key Points: 
  • The partnership between LSEG and FlexTrade will enable new mutual clients access to FXall execution services from within the FlexFX EMS.
  • FlexTrade and LSEG will offer the option of an integrated solution to new mutual clients while continuing to offer independent FX solutions via FlexFX EMS and FXall, respectively.
  • Our priority at LSEG is to understand our clients’ FX needs and meet them where they want to trade.
  • Moreover, the integration of FlexFX into the FlexTRADER EMS will continue to deliver zero-compromise, market-leading capabilities to our multi-asset clients.”

Donor Network West, MTF Biologics and Family of U.S. Marine and Organ Donor Hero Gather for Rose Dedication Memorial Ceremony

Retrieved on: 
Wednesday, December 13, 2023
Surgery, Veterans, Entertainment, Military, Events, Concerts, Other Health, Biotechnology, General Health, Health, Defense, MTF, Research, Hope, Dance, Transplant, Liver, Tissue, Multimedia, Pancreas, Darkness, Tournament, Crash, Family, Quality of life, Rose Parade, Travel, Cultured pearl, Pharmaceutical industry, Life

As a U.S. Marine and big brother to two sisters, he is described as someone who put others before himself.

Key Points: 
  • As a U.S. Marine and big brother to two sisters, he is described as someone who put others before himself.
  • Through organ and tissue donation, Messina was able to provide one last act of kindness in service to others.
  • As a tissue donor, he was able to help more than 100 people regain mobility and enjoy a better quality of life.
  • Matthew’s story highlights the important work of MTF Biologics and Donor Network West, saving and healing lives," said Joe Yaccarino, President, and CEO, MTF Biologics.

United States Sex Reassignment Hormone Therapy (Male-To-Female, Female-To-Male) Market Size, Share & Trends Analysis Report 2023-2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 12, 2023
LGBTQ+, Pharmaceutical, Health, Consumer, MTF, Testosterone, Market, Therapy, FTM, Therapeutic use exemption, Patient, USD, LGBTQ, Puberty, Novartis, Viatris, Gender transition, Growth, Pfizer, DUAVEE, AbbVie, Pharmacy, Birth control

Sex Reassignment Hormone Therapy Market Size, Share & Trends Analysis Report By Gender Transition (Male-To-Female, Female-To-Male), By Type (Puberty Blockers, Estrogen), By Distribution Channel, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Sex Reassignment Hormone Therapy Market Size, Share & Trends Analysis Report By Gender Transition (Male-To-Female, Female-To-Male), By Type (Puberty Blockers, Estrogen), By Distribution Channel, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The U. S. sex reassignment hormone therapy market size is expected to reach USD 2.23 billion by 2030, growing at a CAGR of 4.05%
    The growth is attributed to the increasing awareness about sex reassignment treatments and the rising patient pool seeking gender affirmation surgery and hormonal therapy.
  • Hormone therapy is a more economical solution than surgical procedures in gender-affirming care.
  • The increased awareness about available options for sex reassignment treatment, supportive governmental regulations for the LGBTQ community, and the emergence of novel hormonal therapies with enhanced efficacy are expected to drive the growth of the U. S. market for sex reassignment hormone therapy.

RayNeo Air 2 XR Glasses Revolutionize Wearable Display User Experience, Launched on Amazon US

Retrieved on: 
Thursday, November 9, 2023
Steam Deck, Nose, Sale, PPD, TCL, PlayStation, Temperature, SRGB, Pressure, Face, FOV, Dizziness, News, Xbox, Nintendo Switch, Sony, Immersion, Environment, MTF, XR, Privacy, MicroLED, RRP, Amazon, Anxiety, AR, Personal computer, Flicker-free, 1080p, Video game, Telescopic sight, Television, Online shopping

The RayNeo Air 2 marks RayNeo's latest achievement in consumer-focused wearable displays, following the groundbreaking success of the RayNeo X2 true AR glasses -- the world's first binocular full-color MicroLED optical waveguide AR glasses.

Key Points: 
  • IRVINE, Calif., Nov. 8, 2023 /PRNewswire/ -- RayNeo™, an industry leader in consumer-grade augmented reality (AR) innovation, has launched its latest RayNeo Air 2 XR glasses for the global markets.
  • The RayNeo Air 2 marks RayNeo's latest achievement in consumer-focused wearable displays, following the groundbreaking success of the RayNeo X2 true AR glasses -- the world's first binocular full-color MicroLED optical waveguide AR glasses.
  • Riding the wave of display breakthroughs, the RayNeo Air 2 aims to enhance the holistic user experience of XR wearables.
  • Recognizing valuable feedback from our users, RayNeo has incorporated a personal touch to the latest RayNeo Air 2 glasses.

Veteran Energy Executive, Mark Little, Joins General Fusion’s Board of Directors

Retrieved on: 
Tuesday, October 31, 2023
Magnetized target fusion, General Fusion, Organization, Electricity, Maintenance, MTF, CO2, Climate change, Renewable energy, Lithium

RICHMOND, British Columbia, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Today, General Fusion announced the appointment of Mark Little to its Board of Directors.

Key Points: 
  • RICHMOND, British Columbia, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Today, General Fusion announced the appointment of Mark Little to its Board of Directors.
  • From its inception, General Fusion has been committed to developing a unique approach to fusion energy that will practically provide zero-carbon fusion energy to the electricity grid by the early to mid-2030s.
  • I firmly believe that General Fusion’s zero-carbon technology will be transformative in the fight against climate change,” said Mark Little.
  • “His support will help ensure we continue to advance our mission of providing practical fusion energy to the electricity grid within the next decade.”

General Fusion and TRIUMF sign MOU to develop key technologies for new LM26 fusion machine

Retrieved on: 
Wednesday, October 25, 2023
Knowledge, Science, General Fusion, Plasma, Magnetized target fusion, TRIUMF, Power, Electricity, Research, Nuclear physics, MOU, MTF, Physics, Lithium, 3D printing

This groundbreaking machine is designed to reach fusion conditions in 2025 and set a path for scientific breakeven equivalent in 2026.

Key Points: 
  • This groundbreaking machine is designed to reach fusion conditions in 2025 and set a path for scientific breakeven equivalent in 2026.
  • TRIUMF and General Fusion will collaborate on projects in key areas including neutron diagnostics and a state-of-the-art ion temperature diagnostic for LM26.
  • “British Columbia is a hub for technology innovation and General Fusion is pleased to advance our transformative LM26 machine with an organization that is both local and has international renown,” said Greg Twinney, CEO, General Fusion.
  • General Fusion will leverage TRIUMF’s existing capabilities in high energy particle physics, materials science and testing to support the development of General Fusion’s Magnetized Target Fusion technology.

MTF Biologics® Receives First Investigational Device Exemption Approval for Human Acellular Dermal Matrix in Breast Reconstruction

Retrieved on: 
Tuesday, October 24, 2023
Medical Devices, FDA, Health, Other Health, Clinical Trials, General Health, Science, Trial of the century, Food, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, PMA, Research, Investigational device exemption, IDE, Tissue, MTF, Surgeon, Partnership, Safety, Mastectomy, Patient, Doctor of Philosophy, Dermis, Pharmaceutical industry, Medical imaging

This marks the first IDE approval for a human acellular dermal matrix for breast reconstruction granted by FDA and is an important milestone in MTF Biologics pursuing Pre-Market Approval (PMA) for FlexHD® Pliable.

Key Points: 
  • This marks the first IDE approval for a human acellular dermal matrix for breast reconstruction granted by FDA and is an important milestone in MTF Biologics pursuing Pre-Market Approval (PMA) for FlexHD® Pliable.
  • “We are excited to embark on a PMA study for FlexHD® Pliable in breast reconstruction,” said Marc Long, Ph.D., executive vice president of research and development, clinical and medical affairs at MTF Biologics.
  • To support its PMA, MTF Biologics developed a clinical study in collaboration with the FDA to achieve an indication for use in breast reconstruction.
  • The study, which will launch in late 2024, will enroll patients undergoing mastectomy and implant-based breast reconstruction at U.S. institutions.